Works by Litzow, Mark R.


Results: 150
    1
    2
    3

    Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.

    Published in:
    2020
    By:
    • Foss, Francine M.;
    • Wang, Xin Victoria;
    • Luger, Selina M.;
    • Jegede, Opeyemi;
    • Miller, Kenneth B.;
    • Stadtmauer, Edward A.;
    • Whiteside, Theresa L.;
    • Avigan, David E.;
    • Gascoyne, Randall D.;
    • Arber, Daniel;
    • Wagner, Henry;
    • Strair, Roger K.;
    • Hogan, William J.;
    • Sprague, Kellie A.;
    • Lazarus, Hillard M.;
    • Litzow, Mark R.;
    • Tallman, Martin S.;
    • Horning, Sandra J.
    Publication type:
    journal article
    4

    U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
    By:
    • Badar, Talha;
    • Vanegas, Yenny A. Moreno;
    • Nanaa, Ahmad;
    • Foran, James M.;
    • Al-Kali, Aref;
    • Mangaonkar, Abhishek;
    • Murthy, Hemant;
    • Alkhateeb, Hassan B.;
    • Viswanatha, David;
    • He, Rong;
    • Shah, Mithun;
    • Yi, Cecilia Arana;
    • Litzow, Mark R.;
    • Gangat, Naseema;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    5

    Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00908-5
    By:
    • Pitel, Beth A.;
    • Zepeda-Mendoza, Cinthya;
    • Sachs, Zohar;
    • Tang, Hongwei;
    • Shivaram, Suganti;
    • Sharma, Neeraj;
    • Smadbeck, James B.;
    • Smoley, Stephanie A.;
    • Pearce, Kathryn E.;
    • Luoma, Ivy M.;
    • Cook, Joselle;
    • Litzow, Mark R.;
    • Hoppman, Nicole L.;
    • Viswanatha, David;
    • Xu, Xinjie;
    • Ketterling, Rhett P.;
    • Greipp, Patricia T.;
    • Peterson, Jess F.;
    • Baughn, Linda B.
    Publication type:
    Article
    6

    Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
    By:
    • Abdelmagid, Maymona G.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Begna, Kebede H.;
    • Hogan, William J.;
    • Patnaik, Mirinal S.;
    • Hashmi, Shahrukh K.;
    • Elliott, Michelle A.;
    • Alkhateeb, Hassan;
    • Karrar, Omer S.;
    • Fleti, Farah;
    • Elnayir, Mohammed H.;
    • Rivera, Candido E.;
    • Murthy, Hemant S.;
    • Foran, James M.;
    • Kharfan-Dabaja, Mohamed A.;
    • Badar, Talha;
    • Viswanatha, David S.;
    • Reichard, Kaaren K.;
    • Gangat, Naseema
    Publication type:
    Article
    7

    Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
    By:
    • Al-Kali, Aref;
    • Nanaa, Ahmad;
    • Viswanatha, David;
    • He, Rong;
    • Nguyen, Phuong;
    • Jevremovic, Dragan;
    • Foran, James M.;
    • Yi, Cecelia Arana;
    • Greipp, Patricia T.;
    • Gangat, Naseema;
    • Patnaik, Mrinal;
    • Tefferi, Ayalew;
    • Litzow, Mark R.;
    • Mangaonkar, Abhishek A.;
    • Shah, Mithun Vinod;
    • Badar, Talha;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    8

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Article
    9
    10

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    Published in:
    2023
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Letter
    11
    12

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article
    13

    A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.

    Published in:
    2021
    By:
    • Zeidner, Joshua F.;
    • Lin, Tara L.;
    • Vigil, Carlos E.;
    • Fine, Gil;
    • Yair Levy, M.;
    • Nazha, Aziz;
    • Esteve, Jordi;
    • Lee, Daniel J.;
    • Yee, Karen;
    • Dalovisio, Andrew;
    • Wang, Eunice S.;
    • Bergua Burgues, Juan M.;
    • Schriber, Jeffrey;
    • Litzow, Mark R.;
    • Frankfurt, Olga;
    • Castillo, Teresa Bernal Del;
    • Bhatt, Vijaya Raj;
    • Bhatnagar, Bhavana;
    • Mehta, Priyanka;
    • Dillon, Richard
    Publication type:
    Letter
    14

    Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths.

    Published in:
    2021
    By:
    • Mangaonkar, Abhishek A.;
    • Ferrer, Alejandro;
    • Vairo, Filippo Pinto E.;
    • Hammel, Caleb W.;
    • Prochnow, Carri;
    • Gangat, Naseema;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Peters, Steve G.;
    • Scott, J. P.;
    • Utz, James P.;
    • Baqir, Misbah;
    • Carmona-Porquera, Eva M.;
    • Kalra, Sanjay;
    • Sekiguchi, Hiroshi;
    • Khan, Shakila P.;
    • Simonetto, Douglas A.;
    • Klee, Eric W.;
    • Kamath, Patrick S.;
    • Roden, Anja C.
    Publication type:
    Letter
    15

    Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes.

    Published in:
    2021
    By:
    • Abdel-Rahman, Zaid H.;
    • Heckman, Michael G.;
    • Anagnostou, Theodora;
    • White, Launia J.;
    • Kloft‐Nelson, Sara M.;
    • Knudson, Ryan A.;
    • Alkhateeb, Hassan B.;
    • Sproat, Lisa Z.;
    • Khera, Nandita;
    • Murthy, Hemant S.;
    • Ayala, Ernesto;
    • Hogan, William J.;
    • Roy, Vivek;
    • Peterson, Jess F.;
    • Kharfan-Dabaja, Mohamed A.;
    • Ketterling, Rhett P.;
    • Litzow, Mark R.;
    • Baughn, Linda B.;
    • Patnaik, Mrinal;
    • Greipp, Patricia T.
    Publication type:
    Letter
    16
    17

    Mayo Clinic experience with 1123 adults with acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00435-1
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Naseema Gangat;
    • Elliott, Michelle A.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Christopher Hook, C.;
    • Wolanskyj-Spinner, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    18
    19

    A population-based study of chronic neutrophilic leukemia in the United States.

    Published in:
    2020
    By:
    • Ruan, Gordon J.;
    • Smith, Caleb J.;
    • Day, Courtney;
    • Harmsen, William S.;
    • Zblewski, Darci L.;
    • Alkhateeb, Hassan;
    • Begna, Kebede;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William;
    • Szuber, Natasha;
    • Gangat, Naseema;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Go, Ronald S.;
    • Shah, Mithun V.
    Publication type:
    Letter
    20
    21

    Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 12, p. 2811, doi. 10.1080/10428194.2020.1783444
    By:
    • Hu, Bei;
    • Lin, Xiao;
    • Lee, Hans C.;
    • Huang, Xuelin;
    • Tidwell, Rebecca S. Slack;
    • Ahn, Kwang Woo;
    • Hu, Zhen-Huan;
    • Jabbour, Elias;
    • Verstovsek, Srdan;
    • Ravandi, Farhad;
    • Garcia-Manero, Guillermo;
    • Kharfan-Dabaja, Mohamed A.;
    • Hossain, Nasheed M.;
    • Marks, David I.;
    • Kamble, Rammuriti T.;
    • Inamoto, Yoshihiro;
    • Kindwall-Keller, Tamila;
    • Saad, Ayman;
    • Litzow, Mark R.;
    • Savani, Bipin N.
    Publication type:
    Article
    22

    Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1592, doi. 10.1080/10428194.2020.1737684
    By:
    • Bubik, Rachel J.;
    • Barth, Dylan M.;
    • Hook, Christopher;
    • Wolf, Robert C.;
    • Muth, Jessica M.;
    • Mara, Kristin;
    • Patnaik, Mrinal S.;
    • Pruthi, Rajiv K.;
    • Marshall, Ariela L.;
    • Litzow, Mark R.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Begna, Kebede H.;
    • Alkhateeb, Hassan;
    • Pardanani, Animesh;
    • Ashrani, Aneel A.;
    • Call, Timothy G.;
    • Rivera, Candido E.;
    • Camoriano, John K.
    Publication type:
    Article
    23

    Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 6, p. 1455, doi. 10.1080/10428194.2020.1723013
    By:
    • Pine, Alexander B.;
    • Chokr, Nora;
    • Stahl, Maximilian;
    • Steensma, David P.;
    • Sekeres, Mikkael A.;
    • Litzow, Mark R.;
    • Luger, Selina M.;
    • Stone, Richard M.;
    • Greenberg, Peter L.;
    • Bejar, Rafael;
    • Bewersdorf, Jan P.;
    • Gore, Steven D.;
    • Zeidan, Amer M.
    Publication type:
    Article
    24

    Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 990, doi. 10.1080/10428194.2018.1509318
    By:
    • Miller, Kevin C.;
    • Al-Kali, Aref;
    • Shah, Mithun V.;
    • Hogan, William J.;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Viswanatha, David S.;
    • He, Rong;
    • Greipp, Patricia T.;
    • Sproat, Lisa Z.;
    • Foran, James M.;
    • Litzow, Mark R.;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    25
    26
    27

    Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 11, p. 2588, doi. 10.1080/10428194.2017.1312384
    By:
    • Barreto, Jason N.;
    • McCullough, Kristen B.;
    • Peskey, Candy S.;
    • Dierkhising, Ross A.;
    • Mara, Kristin C.;
    • Elliott, Michelle A.;
    • Gastineau, Dennis A.;
    • Al-Kali, Aref;
    • Gangat, Naseema;
    • Letendre, Louis;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    28
    29
    30

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    31

    Comparison of complication rates of Hickman<sup>®</sup> catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 6, p. 1263, doi. 10.3109/10428194.2012.742520
    By:
    • Lim, Ming Y.;
    • Al-Kali, Aref;
    • Ashrani, Aneel A.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Hook, C. Christopher;
    • Kaufmann, Scott H.;
    • Letendre, Louis;
    • Litzow, Mark R.;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Wolanskyj, Alexandra P.;
    • Grill, Diane E.;
    • Pruthi, Rajiv K.
    Publication type:
    Article
    32

    Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.

    Published in:
    Journal of Cutaneous Pathology, 2017, v. 44, n. 12, p. 1087, doi. 10.1111/cup.13019
    By:
    • Lehman, Julia S.;
    • Hashmi, Shahrukh K.;
    • Lazarus, Hillard M.;
    • el‐Azhary, Rokea A.;
    • Gibson, Lawrence E.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Patnaik, Mrinal S.;
    • Buadi, Francis;
    • Lacy, Martha Q.;
    • Dasari, Surendra;
    • Vanderboom, Patrick;
    • Meves, Alexander
    Publication type:
    Article
    33

    Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.

    Published in:
    Acta Haematologica, 2016, v. 136, n. 4, p. 210, doi. 10.1159/000448160
    By:
    • Baljevic, Muhamed;
    • Dumitriu, Bogdan;
    • Lee, Ju-Whei;
    • Paietta, Elisabeth M.;
    • Wiernik, Peter H.;
    • Racevskis, Janis;
    • Chen, Christina;
    • Stein, Eytan M.;
    • Gallagher, Robert E.;
    • Rowe, Jacob M.;
    • appelbaum, Frederick R.;
    • Powell, Bayard L.;
    • Larson, Richard a.;
    • Coutré, Steven E.;
    • Lancet, Jeffrey;
    • Litzow, Mark R.;
    • Luger, Selina M.;
    • Young, Neal S.;
    • Tallman, Martin S.
    Publication type:
    Article
    34
    35

    Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 5, p. 830, doi. 10.1002/ajh.27651
    By:
    • Acosta‐Medina, Aldo A.;
    • Sridharan, Meera;
    • Go, Ronald S.;
    • Moyer, Ann M.;
    • Leung, Nelson;
    • Willrich, Maria Alice V.;
    • Wolf, Robert;
    • Kassis, Rabee;
    • Manasrah, Almothana;
    • Kohorst, Mira A.;
    • Durani, Urshila;
    • Matin, Aasiya;
    • Hefazi, Mehrdad;
    • Kenderian, Saad J.;
    • Mangaonkar, Abhishek A.;
    • Shah, Mithun V.;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Dingli, David;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    36

    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 260, doi. 10.1002/ajh.27564
    By:
    • Gangat, Naseema;
    • Elbeih, Azeem;
    • Ghosoun, Nour;
    • McCullough, Kristen;
    • Aperna, Fnu;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Mangaonkar, Abhishek;
    • Matin, Aasiya;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh
    Publication type:
    Article
    37

    Building a better blinatumomab.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 4, p. 512, doi. 10.1002/ajh.27253
    By:
    • Litzow, Mark R.
    Publication type:
    Article
    38

    Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 4, p. 606, doi. 10.1002/ajh.27231
    By:
    • Abaza, Yasmin;
    • Winer, Eric S.;
    • Murthy, Guru Subramanian Guru;
    • Shallis, Rory M.;
    • Matthews, Andrew H.;
    • Badar, Talha;
    • Geramita, Emily M.;
    • Kota, Vamsi K.;
    • Swaroop, Alok;
    • Doukas, Peter;
    • Bradshaw, Danielle;
    • Helenowski, Irene B.;
    • Liu, Yingzhe;
    • Zhang, Hui;
    • Im, Annie;
    • Litzow, Mark R.;
    • Perl, Alexander E.;
    • Atallah, Ehab;
    • Altman, Jessica K.
    Publication type:
    Article
    39

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
    By:
    • Karrar, Omer;
    • Abdelmagid, Maymona;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant;
    • Foran, James
    Publication type:
    Article
    40

    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
    By:
    • Gangat, Naseema;
    • Karrar, Omer;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Abdallah, Mostafa;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant
    Publication type:
    Article
    41

    Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
    By:
    • Mangaonkar, Abhishek A.;
    • Langer, Kimberly J.;
    • Lasho, Terra L.;
    • Finke, Christy;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Go, Ronald S.;
    • Bartoo, Gabriel;
    • Kutzke, Jade;
    • McCullough, Kristen B.;
    • Koster, Matthew;
    • Samec, Matthew;
    • Warrington, Kenneth J.;
    • Reichard, Kaaren K.;
    • Olteanu, Horatiu;
    • Riwes, Mary;
    • Patnaik, Mrinal M.;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    42
    43

    A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
    By:
    • Tefferi, Ayalew;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Shah, Mithun;
    • Patnaik, Mrinal S.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Mangaonkar, Abhishek;
    • Viswanatha, David;
    • Chen, Dong;
    • Pardanani, Animesh;
    • Ketterling, Rhett P.;
    • DiNardo, Courtney D.;
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Sasaki, Koji;
    • Begna, Kebede H.
    Publication type:
    Article
    44

    Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 7, p. E232, doi. 10.1002/ajh.26546
    By:
    • Badar, Talha;
    • Atallah, Ehab;
    • Shallis, Rory M.;
    • Goldberg, Aaron D.;
    • Patel, Anand;
    • Abaza, Yasmin;
    • Bewersdorf, Jan P.;
    • Saliba, Antoine N.;
    • Correia, Guilherme Sacchi De Camargo;
    • Murthy, Guru;
    • Duvall, Adam;
    • Burkart, Madelyn;
    • Stahl, Maximilian;
    • Liu, Yuanhang;
    • Dinner, Shira;
    • Palmisiano, Neil;
    • Litzow, Mark R.;
    • Foran, James M.
    Publication type:
    Article
    45

    Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Johnson, Isla;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Sproat, Lisa;
    • Arana Yi, Cecilia Y.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    46
    47
    48
    49

    Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
    By:
    • Gangat, Naseema;
    • Guglielmelli, Paola;
    • Szuber, Natasha;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Alkhateeb, Hassan;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Pardanani, Animesh;
    • Mannelli, Francesco;
    • Vannucchi, Alessandro M.;
    • Tefferi, Ayalew
    Publication type:
    Article
    50

    Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
    By:
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article